Qiuhong Li

Qiuhong Li, PhD

Associate Professor

Department: MD-OPHTHALMOLOGY
Business Phone: (352) 273-7540
Business Email: qli@ufl.edu

Teaching Profile

Courses Taught
2013-2015
GMS6417 Integrative Aging Physiology
2015
GMS6709 Current Topics in Vision
2015
GMS6683 Fundamentals of Vascular Physiology and Pathology
2013
PHA6971 Research for Master’s Thesis

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0003-4211-6514

Publications

2022
Probiotic Releasing Angiotensin (1-7) in a Drosophila Model of Alzheimer’s Disease Produces Sex-Specific Effects on Cognitive Function.
Journal of Alzheimer's disease : JAD. 85(3):1205-1217 [DOI] 10.3233/JAD-210464. [PMID] 34924372.
2020
ACE2 as therapeutic agent
Clinical Science. 134(19):2581-2595 [DOI] 10.1042/cs20200570.
2020
Expression and Function of Mas-Related G Protein-Coupled Receptor D and Its Ligand Alamandine in Retina
Molecular Neurobiology. 57(1):513-527 [DOI] 10.1007/s12035-019-01716-4.
2018
Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice.
Diabetes. 67(9):1867-1879 [DOI] 10.2337/db18-0158. [PMID] 29712667.
2017
A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization.
Journal of cellular and molecular medicine. 21(8):1555-1571 [DOI] 10.1111/jcmm.13086. [PMID] 28332318.
2016
AAV-Mediated Clarin-1 Expression in the Mouse Retina: Implications for USH3A Gene Therapy.
PloS one. 11(2) [DOI] 10.1371/journal.pone.0148874. [PMID] 26881841.
2016
AAV8-Mediated Angiotensin-Converting Enzyme 2 Gene Delivery Prevents Experimental Autoimmune Uveitis by Regulating MAPK, NF-κB and STAT3 Pathways.
Scientific reports. 6 [DOI] 10.1038/srep31912. [PMID] 27558087.
2016
Adeno-Associated Virus Overexpression of Angiotensin-Converting Enzyme-2 Reverses Diabetic Retinopathy in Type 1 Diabetes in Mice.
The American journal of pathology. 186(6):1688-700 [DOI] 10.1016/j.ajpath.2016.01.023. [PMID] 27178803.
2016
Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.
Investigative ophthalmology & visual science. 57(15):6722-6730 [DOI] 10.1167/iovs.16-20289. [PMID] 27951594.
2015
Gene delivery of a viral anti-inflammatory protein to combat ocular inflammation.
Human gene therapy. 26(1):59-68 [DOI] 10.1089/hum.2014.089. [PMID] 25420215.
2014
Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy–a study in transgenic (mREN2)27 rats.
PloS one. 9(6) [DOI] 10.1371/journal.pone.0100954. [PMID] 24968134.
2014
Ocular Endoplasmic Reticulum Stress and Inflammation Is Attenuated By Supplementation With Muscadine Grape Polyphenols in Vitro and in Vivo
The FASEB's Journal. 28(1, S)
2014
Oral delivery of ACE2/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis.
Molecular therapy : the journal of the American Society of Gene Therapy. 22(12):2069-2082 [DOI] 10.1038/mt.2014.179. [PMID] 25228068.
2014
Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension.
Hypertension (Dallas, Tex. : 1979). 64(6):1248-59 [DOI] 10.1161/HYPERTENSIONAHA.114.03871. [PMID] 25225206.
2014
Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers.
Molecular therapy : the journal of the American Society of Gene Therapy. 22(3):535-546 [DOI] 10.1038/mt.2013.273. [PMID] 24281246.
2013
Chronic knockdown of the nucleus of the solitary tract AT1 receptors increases blood inflammatory-endothelial progenitor cell ratio and exacerbates hypertension in the spontaneously hypertensive rat.
Hypertension (Dallas, Tex. : 1979). 61(6):1328-33 [DOI] 10.1161/HYPERTENSIONAHA.111.00156. [PMID] 23547238.
2013
Expression of Adiponectin and Its Receptors in Type 1 Diabetes Mellitus in Human and Mouse Retinas
Molecular Vision. 19:1769-1778
2013
Nucleus of the solitary tract (pro)renin receptor-mediated antihypertensive effect involves nuclear factor-κB-cytokine signaling in the spontaneously hypertensive rat.
Hypertension (Dallas, Tex. : 1979). 61(3):622-7 [DOI] 10.1161/HYPERTENSIONAHA.111.199836. [PMID] 23319541.
2012
ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy.
Molecular therapy : the journal of the American Society of Gene Therapy. 20(1):28-36 [DOI] 10.1038/mt.2011.155. [PMID] 21792177.
2012
Aqueous humor and plasma adiponectin levels in proliferative diabetic retinopathy patients.
Current eye research. 37(9):803-8 [DOI] 10.3109/02713683.2012.676700. [PMID] 22563689.
2012
Nts (Pro)Renin Receptor (Prr)-Mediated Antihypertensive Effect Involves Nf-Kappab-Cytokine Signaling in the Spontaneously Hypertensive Rats (Shr)
The FASEB's Journal. 26
2012
Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS rats.
Investigative ophthalmology & visual science. 53(4):1895-904 [DOI] 10.1167/iovs.11-8831. [PMID] 22408006.
2011
(Pro)Renin Receptor (Prr) Mediates Antihypertensive Effects in the Necleus of Solitary Tract (Nts) of Spontaneously Hypertensive Rats (Shr)
Hypertension. 58
2011
Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells.
Investigative ophthalmology & visual science. 52(8):5093-104 [DOI] 10.1167/iovs.10-70911. [PMID] 21676908.
2011
Endothelial dysfunction as a potential contributor in diabetic nephropathy.
Nature reviews. Nephrology. 7(1):36-44 [DOI] 10.1038/nrneph.2010.152. [PMID] 21045790.
2011
Inhibition of choroidal neovascularization in a nonhuman primate model by intravitreal administration of an AAV2 vector expressing a novel anti-VEGF molecule.
Molecular therapy : the journal of the American Society of Gene Therapy. 19(2):260-5 [DOI] 10.1038/mt.2010.230. [PMID] 20978476.
2011
Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina.
Molecular therapy : the journal of the American Society of Gene Therapy. 19(2):293-301 [DOI] 10.1038/mt.2010.234. [PMID] 21045809.
2010
Achromatopsia as a potential candidate for gene therapy.
Advances in experimental medicine and biology. 664:639-46 [DOI] 10.1007/978-1-4419-1399-9_73. [PMID] 20238068.
2010
Selective tropism of the recombinant adeno-associated virus 9 serotype for rat cardiac tissue.
The journal of gene medicine. 12(1):22-34 [DOI] 10.1002/jgm.1404. [PMID] 19830780.
2010
Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice.
American journal of physiology. Renal physiology. 298(3):F609-16 [DOI] 10.1152/ajprenal.00377.2009. [PMID] 20015944.
2009
Dose-Dependent Humoral Immune Responses To Intravitreal Delivery of Aav Vectors and Strategies To Circumvent
Molecular Therapy. 17
2009
Gene Therapy Following Subretinal Aav5 Vector Delivery Is Not Affected By a Previous Intravitreal Aav5 Vector Administration in the Partner Eye
Molecular Vision. 15:267-275
2009
Gene therapy for red-green colour blindness in adult primates.
Nature. 461(7265):784-7 [DOI] 10.1038/nature08401. [PMID] 19759534.
2009
High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors.
Molecular therapy : the journal of the American Society of Gene Therapy. 17(3):463-71 [DOI] 10.1038/mt.2008.269. [PMID] 19066593.
2009
Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice.
The American journal of pathology. 174(4):1221-9 [DOI] 10.2353/ajpath.2009.080605. [PMID] 19246639.
2008
AAV-mediated gene therapy for retinal degeneration in the rd10 mouse containing a recessive PDEbeta mutation.
Investigative ophthalmology & visual science. 49(10):4278-83 [DOI] 10.1167/iovs.07-1622. [PMID] 18586879.
2008
Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of serotype and site of administration.
Vision research. 48(3):377-85 [PMID] 17950399.
2008
Cone-specific expression using a human red opsin promoter in recombinant AAV.
Vision research. 48(3):332-8 [PMID] 17905404.
2008
Downregulation of p22phox in retinal pigment epithelial cells inhibits choroidal neovascularization in mice.
Molecular therapy : the journal of the American Society of Gene Therapy. 16(10):1688-94 [DOI] 10.1038/mt.2008.164. [PMID] 18665154.
2008
Intraocular Route of Aav2 Vector Administration Defines Humoral Immune Response and Therapeutic Potential
Molecular vision. 14:1760-1769
2006
Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis.
Molecular therapy : the journal of the American Society of Gene Therapy. 13(3):565-72 [PMID] 16223604.
2001
Noninvasive imaging by optical coherence tomography to monitor retinal degeneration in the mouse.
Investigative ophthalmology & visual science. 42(12):2981-9 [PMID] 11687546.

Grants

Feb 2024 ACTIVE
Fee for Service MUSC
Role: Principal Investigator
Funding: MEDICAL UNIV OF SOUTH CAROLINA
Sep 2023 ACTIVE
Pro/renin receptor-mediated signaling in pathogenesis of diabetic retinopathy
Role: Principal Investigator
Funding: NATL INST OF HLTH NEI
Aug 2023 ACTIVE
Engineering next generation probiotics for delivery of therapeutics
Role: Principal Investigator
Funding: MEDOSOME BIOTEC via NATL INST OF HLTH NEI
Dec 2022 ACTIVE
Genetically modified bacteria: Lactobacillus expression vectors producing ACE2 (LP-ACE2) and Ang-1-7 (LP-Ang-1-7) with codon usage optimized for high level expression in different species of Lactobacillus.
Role: Principal Investigator
Funding: UNIV OF ALABAMA BIRMINGHAM via NATL INST OF HLTH NEI
Dec 2021 – Nov 2022
Role of Ang(17)-secreting Lactobacillus paracasei (LP) in regulating Hypertension: Piloting Dosing Strategies
Role: Principal Investigator
Funding: WAKE FOREST UNIV
Sep 2019 – Aug 2021
Optimization of food-grade recombinant probiotics for oral delivery of ACE2/Ang-(1-7)
Role: Co-Investigator
Funding: MEDOSOME BIOTEC via NATL INST OF HLTH NHLBI
Jun 2019 – May 2021
Fee for Service Contract with University of Alabama (UAB)
Role: Principal Investigator
Funding: UNIV OF ALABAMA BIRMINGHAM
May 2018 – Apr 2023
ACE2 Modulates the Bone Marrow- Gut Axis in Diabetic Retinopathy
Role: Principal Investigator
Funding: UNIV OF ALABAMA BIRMINGHAM via NATL INST OF HLTH NEI
Aug 2016 – Dec 2021
ACE2, Brain, Gut Dysbiosis in Pulmonary Hypertension
Role: Co-Investigator
Funding: NATL INST OF HLTH NHLBI
Sep 2015 – Aug 2020
Oral therapy for diabetic retinopathy using ACE2/Ang1-7 bioencapsulated in plant cells
Role: Principal Investigator
Funding: NATL INST OF HLTH NEI
Jul 2015 – Jun 2017
Ang-(1-7)/Mas Signaling in Aging Eye- Protective Mechanisms and Therapeutic Potential
Role: Principal Investigator
Funding: BRIGHTFOCUS FOU
Jan 2015 – Dec 2017
Oral delivery of bioencapsulated ACE2 and Ang1-7 for therapy of diabetic retinopathy
Role: Principal Investigator
Funding: AMER DIABETES ASSOCIATION
Jan 2012 – Dec 2016
Ocular Renin Angotensin System in Pathogenesis of Diabetic Retinopathy
Role: Principal Investigator
Funding: NATL INST OF HLTH NEI

Contact Details

Phones:
Business:
(352) 273-7540
Emails:
Business:
qli@ufl.edu
Addresses:
Business Mailing:
PO Box 100284
GAINESVILLE FL 32610
Business Street:
MSB JHMHC
GAINESVILLE FL 32611